Newsroom
Press Releases
Nov 14, 2022
Lanier Biotherapeutics Announces Issuance of U.S. Patent for IL-25 Binding Molecules
Read More
May 13, 2022
Lanier Biotherapeutics to Present Seminal LNR125 Publication at American Thoracic Society Meeting
Read More
Oct 6, 2021
Newly Formed Lanier Biotherapeutics Enters into License Agreement with Alloy Therapeutics
Read More
In The News
July 9, 2021
Molecular Templates, Inc. Announces Dosing of First Subject in Phase 1 Study of MT-6402 in PD-L1-Positive Solid Tumors
Read More